The CRAFFT cut-points and DSM-5 criteria for alcohol and other drugs: A reevaluation and reexamination

Substance Abuse

Volumn 35, Issue 4, 2014, Pages 376-380

  Mitchell, Shannon Gwin ^a   Kelly, Sharon M ^a   Gryczynski, Jan ^a   Myers, C Patrick ^b   Ogrady, Kevin E ^c   Kirk, Arethusa S ^d   Schwartz, Robert P ^a  

^a FRIENDS RESEARCH INSTITUTE   (United States)

^b PM and A Consulting   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d Total Health Care   (United States)

Author keywords

Adolescent; CRAFFT; DSM 5; screening; substance use

Indexed keywords

ADOLESCENT; ALCOHOLISM; CHILD; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; MALE; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; SENSITIVITY AND SPECIFICITY; SUBSTANCE-RELATED DISORDERS;

ADOLESCENT; ALCOHOLISM; CHILD; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SENSITIVITY AND SPECIFICITY; SUBSTANCE-RELATED DISORDERS;

EID: 84918792405     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2014.936992     Document Type: Article

References (18)

1. American Academy of Pediatrics. Substance use screening, brief intervention, and referral to treatment for pediatricians. Pediatrics. 2011;126:e1330-e1340
2. American Academy of Pediatrics. Committee on Substance Abuse. Policy statement-alcohol use by youth and adolescents: a policy concern. Pediatrics. 2010;125:1078-1087
3. Kulig JW. American Academy of Pediatrics Committee on Substance Abuse. Tobacco, alcohol, and other drugs: the role of the pediatrician in prevention, identification, and management of substance abuse. Pediatrics. 2005;115:816-821
4. World Health Organization, Commonwealth Medical Association Trust, UNICEF. Orientation Programme on Adolescent Health for Health Care Providers. Geneva, Switzerland: World Health Organization; 2006
5. Knight JR, Shrier LA, Bravender TD, Farrell M, Vander Bilt J, Shaffer HJ. A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med. 1999;153:591-596
6. Pilowsky DJ, Wu LT. Screening instruments for substance use and brief interventions targeting adolescents in primary care: a literature review. Addict Behav. 2013;38:2146-2153
7. Knight JR, Sherritt L, Shrier LA, Harris SK, Chang G. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med. 2002;156:607-614
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Arlington, VA: Author; 1994
9. Cook RL, Chung T, Kelly TM, Clark DB. Alcohol screening in young persons attending a sexually transmitted disease clinic. Comparison of AUDIT, CRAFFT, and CAGE instruments. J Gen Intern Med. 2005;20:1-6
10. Cummins LH, Chan KK, Burns KM, Blume AW, Larimer M, Marlatt GA. Validity of the CRAFFT in American-Indian and Alaska-Native adolescents: screening for drug and alcohol risk. J Stud Alcohol. 2003;64:727-732
11. Dhalla S, Zumbo BD, Poole G. A review of the psychometric properties of the CRAFFT instrument: 1999-2010. Curr Drug Abuse Rev. 2011;4:57-64
12. Knight JR, Sherritt L, Harris SK, Gates EC, Chang G. Validity of brief alcohol screening tests among adolescents: a comparison of the AUDIT, POSIT, CAGE, and CRAFFT. Alcohol Clin Exp Res. 2003;27:67-73
13. Levy S, Sherritt L, Harris SK, et al. Test-retest reliability of adolescents' self-report of substance use. Alcohol Clin Exp Res. 2004;28:1236-1241
14. Skogen JC, Boe T, Knudsen AK, Hysing M. Psychometric properties and concurrent validity of the CRAFFT among Norwegian adolescents. Ung@hordaland, a population-based study. Addict Behav. 2013;38:2500-2505
15. Subramaniam M, Cheok C, Verma S, Wong J, Chong SA. Validity of a brief screening instrument-CRAFFT in a multiethnic Asian population. Addict Behav. 2010;35:1102-1104
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: Author; 2013
17. Forman RF, Svikis D, Montoya ID, Blaine J. Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2004;27:1-8
18. Hasin DS, O'Brien CP, Auriacombe M, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013;170:834-851